The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The Meals and Drug Administration (FDA) granted conventional approval to Imdelltra (tarlatamab-dlle) for grownup sufferers with extensive-stage small cell lung most cancers...
The U.S. Meals and Drug Administration has authorized Hyrnuo (sevabertinib) for the remedy of adults with regionally superior or metastatic non-squamous non–small...
